Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. Issue 6 (17th March 2022) - Short, Nicholas J.
Abstract :